Synchronous Presentation of Chronic Myelomonocytic Leukemia and Multiple Myeloma in a Treatment‐Naïve Patient
Case Reports in Hematology · 2026-01 · 2026 (1)
DOI: 10.1155/crh/5531249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Hematology, online erschienen am 12.06.2026. Verfasst von Moutaz W Sweileh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Allied Medical Sciences, An-Najah National University, Nablus, State of Palestine, najah.edu. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Chronic myelomonocytic leukemia (CMML) is a clonal myelodysplastic/myeloproliferative neoplasm characterized by persistent peripheral blood monocytosis and dysplastic bone marrow morphology. Multiple myeloma (MM) is a plasma cell malignancy defined by clonal plasma cell proliferation and myeloma‐defining events. The synchronous occurrence of CMML and MM is exceptionally rare, particularly in treatment‐naïve and relatively young patients. Case Presentation We present a 42‐year‐old‐male presenting with progressive fatigue and leukocytosis. Laboratory evaluation revealed marked absolute monocytosis (16.4 × 10 9 /L), anemia, and neutropenia. Bone marrow examination demonstrated an expanded abnormal monocytic population, further confirmed by multiparametric flow cytometry. Conventional cytogenetic analysis revealed monosomy 7, supporting the presence of a clonal myeloid neoplasm consistent with CMML. Concurrently, bone marrow biopsy showed 10%–15% plasma cells. Serum protein electrophoresis identified an IgG kappa monoclonal paraprotein (3.5 g/dL), and imaging showed a lytic bone lesion and biopsy‐provided extramedullary plasmacytoma, meeting the diagnostic criteria of symptomatic MM. The patient has no prior exposure to cytotoxic therapy. He received one cycle of azacitidine with subsequent worsening cytopenias, underscoring therapeutic complexity.
Conclusions
This case describes a rare concurrent presentation of CMML and MM in a young, treatment‐naïve patient. The combination of persistent monocytosis, dysplastic marrow findings, and monosomy 7 supported the presence of clonal myeloid process coexisting with plasma cell myeloma. Recognizing concurrent hematologic malignancies is essential, as diagnostic overlap and treatment interactions present substantial management challenges. Additional molecular characterization of similar cases may elucidate potential pathogenetic connections and guide tailored therapeutic approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Allied Medical Sciences, An-Najah National University, Nablus, State of Palestine, najah.edu.
- Department of Pathology, An-Najah National University Hospital, Nablus, State of Palestine, najah.edu.
- Department of Pathology & Laboratory Medicine, Royal Liverpool University Hospital, Liverpool, UK, nhs.uk.
- Department of Internal Medicine, An-Najah National University Hospital, Nablus, State of Palestine, najah.edu.
ORCID-Profile: Moutaz W Sweileh
Zitieren
APA
Sweileh, M. W., Qamhia, N., Batta, A., Asaad, H., Odeh, R. Y., & Swaileh, M. (2026). Synchronous Presentation of Chronic Myelomonocytic Leukemia and Multiple Myeloma in a Treatment‐Naïve Patient. Case Reports in Hematology, 2026(1). https://doi.org/10.1155/crh/5531249
Vancouver
Sweileh MW, Qamhia N, Batta A, Asaad H, Odeh RY, Swaileh M. Synchronous Presentation of Chronic Myelomonocytic Leukemia and Multiple Myeloma in a Treatment‐Naïve Patient. Case Reports in Hematology. 2026;2026(1). doi:10.1155/crh/5531249
BibTeX
@article{Sweileh2026,
author = {Sweileh, Moutaz W and Qamhia, Naim and Batta, Amal and Asaad, Hisham and Odeh, Razan Yousef and Swaileh, Mamoun},
title = {Synchronous Presentation of Chronic Myelomonocytic Leukemia and Multiple Myeloma in a Treatment‐Naïve Patient},
journal = {Case Reports in Hematology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crh/5531249}
}
EUVIMED